TY  - JOUR

T1  - tAnGo: A randomized phase III trial of gemcitabine (gem) in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy (CT) for women with early-stage breast cancer (EBC)

JO  - Journal of Clinical Oncology

PY  - 2008/05/20

AU  - Poole CJ

AU  - Hiller L

AU  - Howard HC

AU  - Dunn JA

AU  - Canney P

AU  - Wardley AM

AU  - Kennedy MJ

AU  - Coleman RE

AU  - Leonard RC

AU  - Earl HM

ED  - 

DO  - DOI: 10.1200/jco.2008.26.15_suppl.506

PB  - American Society of Clinical Oncology (ASCO)

VL  - 26

IS  - 15_suppl

SP  - 506

EP  - 506

Y2  - 2025/10/10

ER  -